Skip Navigation



eCAM Advance Access published online on July 10, 2009

eCAM, doi:10.1093/ecam/nep066
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chiou, W.-F.
Right arrow Articles by Wei, B.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiou, W.-F.
Right arrow Articles by Wei, B.-L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2009 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

8-Prenylkaempferol Suppresses Influenza A Virus-Induced RANTES Production in A549 Cells via Blocking PI3K-Mediated Transcriptional Activation of NF-{kappa}B and IRF3

Wen-Fei Chiou1,2,3, Chen-Chih Chen1 and Bai-Luh Wei2

1National Research Institute of Chinese Medicine, Taipei,2Institute of Life Science, Collage of Science and Engineering, National Taitung University, Taitung and 3Institute of Traditional Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan

8-Prenylkaempferol (8-PK) is a prenylflavonoid isolated from Sophora flavescens, a Chinese herb with antiviral and anti-inflammatory properties. In this study, we investigated its effect on regulated activation, normal T cell expressed and secreted (RANTES) secretion by influenza A virus (H1N1)-infected A549 alveolar epithelial cells. Cell inoculation with H1N1 evoked a significant induction in RANTES accumulation accompanied with time-related increase in nuclear translocation of nuclear factor-{kappa}B (NF-{kappa}B) and interferon regulatory factor 3 (IRF-3), but showed no effect on c-Jun phosphorylation. 8-PK could significantly inhibit not only RANTES production but also NF-{kappa}B and IRF-3 nuclear translocation. We had proved that both NF-{kappa}B and IRF-3 participated in H1N1-induced RANTES production since NF-{kappa}B inhibitor pyrrolidinedithio carbamate (PDTC) and IRF-3 siRNA attenuated significantly RANTES accumulation. H1N1 inoculation also increased PI3K activity as well as Akt phosphorylation and such responsiveness were attenuated by 8-PK. In the presence of wortmannin, nuclear translocation of NF-{kappa}B and IRF3 as well as RANTES production by H1N1 infection were all reversed, demonstrating that PI3K–Akt pathway is essential for NF-{kappa}B- and IRF-3-mediated RANTES production in A549 cells. Furthermore, 8-PK but not wortmannin, prevented effectively H1N1-evoked I{kappa}B degradation. In conclusion, 8-PK might be an anti-inflammatory agent for suppressing influenza A virus-induced RANTES production acts by blocking PI3K-mediated transcriptional activation of NF-{kappa}B and IRF-3 and in part by interfering with I{kappa}B degradation which subsequently decreases NF-{kappa}B translocation.

Keywords: Akt – H1N1 – IRF-3 – NF-{kappa}B – PI3K – 8-prenylkaempferol – RANTES – Sophora flavescens


For reprints and all correspondence: Wen-Fei Chiou, Ph.D., Division of Basic Chinese Medical Research, National Research Institute of Chinese Medicine, No. 155-1, Sec. 2, Li-Nung St, Shipai, Taipei 112, Taiwan, ROC. Tel: +886-2-2820199 (4481); Fax: +886-2-28264343; E-mail: wfchiou{at}cma23.nricm.edu.tw

Received July 10, 2008; accepted June 3, 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.